IL160209A0 - Analysis of circulating tumor cells, fragments, and debris - Google Patents
Analysis of circulating tumor cells, fragments, and debrisInfo
- Publication number
- IL160209A0 IL160209A0 IL16020902A IL16020902A IL160209A0 IL 160209 A0 IL160209 A0 IL 160209A0 IL 16020902 A IL16020902 A IL 16020902A IL 16020902 A IL16020902 A IL 16020902A IL 160209 A0 IL160209 A0 IL 160209A0
- Authority
- IL
- Israel
- Prior art keywords
- analysis
- damage
- debris
- fragments
- vitro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/549—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic with antigen or antibody entrapped within the carrier
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31415101P | 2001-08-23 | 2001-08-23 | |
US36962802P | 2002-04-03 | 2002-04-03 | |
PCT/US2002/026861 WO2003019141A2 (fr) | 2001-08-23 | 2002-08-23 | Analyse de cellules tumorales en circulation, de fragments et de debris associes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160209A0 true IL160209A0 (en) | 2004-07-25 |
Family
ID=26979228
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16021002A IL160210A0 (en) | 2001-08-23 | 2002-08-23 | Stabilization of cells and biological specimens for analysis |
IL16020902A IL160209A0 (en) | 2001-08-23 | 2002-08-23 | Analysis of circulating tumor cells, fragments, and debris |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16021002A IL160210A0 (en) | 2001-08-23 | 2002-08-23 | Stabilization of cells and biological specimens for analysis |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1425383A4 (fr) |
JP (3) | JP2005501236A (fr) |
KR (2) | KR20040053115A (fr) |
CN (2) | CN1571634A (fr) |
AT (1) | ATE401574T1 (fr) |
AU (2) | AU2008288601B2 (fr) |
BR (2) | BR0212124A (fr) |
CA (2) | CA2457894C (fr) |
DE (1) | DE60227678D1 (fr) |
IL (2) | IL160210A0 (fr) |
WO (2) | WO2003019141A2 (fr) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7863012B2 (en) | 2004-02-17 | 2011-01-04 | Veridex, Llc | Analysis of circulating tumor cells, fragments, and debris |
JP2005501236A (ja) * | 2001-08-23 | 2005-01-13 | イムニベスト・コーポレイション | 分析用の細胞および生物学的検体の安定化 |
US8980568B2 (en) | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
CA2484876C (fr) | 2002-05-13 | 2011-11-22 | Becton, Dickinson And Company | Systeme de prelevement d'echantillon comprenant un inhibiteur de protease |
EP2359689B1 (fr) | 2002-09-27 | 2015-08-26 | The General Hospital Corporation | Dispositif microfluidique pour la séparation de cellules et usage du dispositif |
EP1413874A1 (fr) | 2002-10-16 | 2004-04-28 | Streck Laboratories, Inc. | Méthode et appareil pour collecter et préserver des cellules pour l'analyse |
WO2004076643A2 (fr) | 2003-02-27 | 2004-09-10 | Immunivest Corporation | Cellules tumorales circulantes (ctc): evaluation precoce du temps d'evolution, de la survie et de la reaction aux therapies des patients cancereux metastasiques |
WO2005028663A2 (fr) * | 2003-09-18 | 2005-03-31 | Immunivest Corporation | Systeme d'analyse et de preparation d'echantillon programmable independamment de l'operateur |
EP1861509B1 (fr) * | 2005-03-14 | 2015-09-09 | Janssen Diagnostics, LLC | Méthode de prédiction de survie sans progression et de survie globale, à chaque instant du suivi, au cours du traitement de patientes atteintes du cancer du sein métastatique, utilisant des cellules tumorales circulantes |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
CN101495650B (zh) | 2005-06-20 | 2015-02-04 | 领先细胞医疗诊断有限公司 | 检测单个细胞中的核酸和鉴定异质大细胞群中罕见细胞的方法 |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US8337755B2 (en) | 2006-03-13 | 2012-12-25 | Veridex, Llc | Operator independent programmable sample preparation and analysis system |
PL2027470T3 (pl) | 2006-06-02 | 2013-03-29 | Pfizer Prod Inc | Oznaczenie krążących komórek nowotworowych |
US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
EP2041299A4 (fr) | 2006-07-14 | 2010-01-13 | Aviva Biosciences Corp | Procedes et compositions servant a detecter des cellules rares dans un echantillon biologique |
CN101669031A (zh) * | 2007-02-27 | 2010-03-10 | 森托科隆股份公司 | 使用与细胞外标记物结合的试剂组多重检测肿瘤细胞 |
US20120202189A1 (en) * | 2007-04-16 | 2012-08-09 | Diagnostic Hybrids, Inc. | Rapid, semi-automated method to detect respiratory virus infected cells in direct specimens |
US8003314B2 (en) | 2007-04-16 | 2011-08-23 | Diagnostic Hybrids, Inc. | Methods for direct fluorescent antibody virus detection in liquids |
US8110101B2 (en) | 2007-08-30 | 2012-02-07 | Veridex, Llc | Method and apparatus for imaging target components in a biological sample using permanent magnets |
US7828968B2 (en) | 2007-08-30 | 2010-11-09 | Veridex, Llc | Method and apparatus for imaging target components in a biological sample using permanent magnets |
US8071395B2 (en) | 2007-12-12 | 2011-12-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and apparatus for magnetic separation of cells |
EP2334812B1 (fr) | 2008-09-20 | 2016-12-21 | The Board of Trustees of The Leland Stanford Junior University | Diagnostic non invasif d'aneuploïdie foetale par sequençage |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
NO2398912T3 (fr) | 2009-02-18 | 2018-02-10 | ||
WO2011038403A1 (fr) | 2009-09-28 | 2011-03-31 | Yuling Luo | Procédés de détection de séquences d'acide nucléique à spécificité élevée |
US20120276555A1 (en) | 2009-10-21 | 2012-11-01 | Peter Kuhn | Method of Using Non-Rare Cells to Detect Rare Cells |
US20130171621A1 (en) | 2010-01-29 | 2013-07-04 | Advanced Cell Diagnostics Inc. | Methods of in situ detection of nucleic acids |
JPWO2011099565A1 (ja) * | 2010-02-10 | 2013-06-17 | シスメックス株式会社 | 血液中癌細胞の検出方法及びそれに用いるプログラム |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
EP2572003A4 (fr) | 2010-05-18 | 2016-01-13 | Natera Inc | Procédés de classification de ploïdie prénatale non invasive |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
DE102010020785A1 (de) * | 2010-05-18 | 2011-11-24 | Siemens Aktiengesellschaft | Vorrichtung und Verfahren zum Erkennen von magnetisch markierten Mikroobjekten |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US20120252038A1 (en) * | 2011-04-01 | 2012-10-04 | Chianese David A | Steroid receptor assays |
EP2704740B1 (fr) | 2011-05-04 | 2016-10-05 | Streck, Inc. | Virus grippal porcin inactivé et procédés de préparation |
EP2737317A2 (fr) * | 2011-07-28 | 2014-06-04 | The Trustees Of The University Of Pennsylvania | Méthodes et réactifs pour le diagnostic d'états pathologiques et la caractérisation de cellules tumorales associées à des liquides séreux |
US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
AU2012314515B2 (en) | 2011-09-26 | 2018-03-15 | Preanalytix Gmbh | Stabilisation and isolation of extracellular nucleic acids |
KR102037891B1 (ko) * | 2012-03-09 | 2019-10-30 | 한국전자통신연구원 | 다중 분리 장치 및 혈중 암세포 분리 방법 |
EP2848935A4 (fr) * | 2012-05-10 | 2015-12-09 | Konica Minolta Inc | Procédé d'élimination des globules rouges ainsi que tube de centrifugation pour prélèvement sanguin |
US10724074B2 (en) | 2012-09-25 | 2020-07-28 | Qiagen Gmbh | Stabilisation of biological samples |
US11493428B2 (en) | 2013-03-15 | 2022-11-08 | Gpb Scientific, Inc. | On-chip microfluidic processing of particles |
US20150064153A1 (en) | 2013-03-15 | 2015-03-05 | The Trustees Of Princeton University | High efficiency microfluidic purification of stem cells to improve transplants |
CN113512522A (zh) | 2013-03-15 | 2021-10-19 | 普林斯顿大学理事会 | 用于高通量纯化的方法和设备 |
JP6381628B2 (ja) | 2013-03-18 | 2018-08-29 | キアゲン ゲーエムベーハー | 生物試料の安定化 |
EP2976425B1 (fr) * | 2013-03-18 | 2019-11-06 | Qiagen GmbH | Stabilisation et isolation d'acides nucléiques extracellulaires |
US10091984B2 (en) | 2013-07-24 | 2018-10-09 | Streck, Inc. | Compositions and methods for stabilizing circulating tumor cells |
EP3502270B1 (fr) | 2013-10-21 | 2020-03-18 | The General Hospital Corporation | Procédés relatifs à des groupes de cellules tumorales circulantes et au traitement du cancer |
US10527624B2 (en) | 2014-01-27 | 2020-01-07 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
EA201691682A1 (ru) | 2014-02-21 | 2017-02-28 | Эпик Сайенсиз, Инк. | Способы анализирования редких циркулирующих в крови клеток |
WO2015140218A1 (fr) * | 2014-03-18 | 2015-09-24 | Qiagen Gmbh | Stabilisation et isolement d'acides nucléiques extracellulaires |
CN103940997B (zh) * | 2014-03-21 | 2017-01-04 | 上海柏慧康生物科技有限公司 | 一种乳腺癌循环肿瘤细胞检测系统及试剂盒 |
CN106460070B (zh) | 2014-04-21 | 2021-10-08 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
CN103980365A (zh) * | 2014-06-03 | 2014-08-13 | 国家纳米科学中心 | 一种表面固载炭疽致死因子的磁性纳米粒子、其制备方法及用途 |
EP3164204B1 (fr) * | 2014-07-02 | 2021-03-10 | Siemens Healthcare Diagnostics Inc. | Séparation d'acides nucléiques sélective |
US10564075B2 (en) | 2015-02-24 | 2020-02-18 | Siemens Healthcare Diagnostics Inc. | Prefixation for increased rare cell recovery |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
WO2016183106A1 (fr) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Procédés et compositions pour la détermination de la ploïdie |
US20170097361A1 (en) * | 2015-07-15 | 2017-04-06 | Streck, Inc. | Method and device for stabilizing of proteins |
JP6617495B2 (ja) * | 2015-09-18 | 2019-12-11 | 東ソー株式会社 | 腫瘍細胞の検出方法 |
WO2017079212A1 (fr) * | 2015-11-04 | 2017-05-11 | Axon Dx, Llc | Détection, capture, analyse et agrégation de cellules, et procédés et appareil de transmission de données |
US11203777B2 (en) | 2015-11-20 | 2021-12-21 | Qiagen Gmbh | Method of preparing sterilized compositions for stabilization of extracellular nucleic acids |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
CN105372109A (zh) * | 2015-12-15 | 2016-03-02 | 苏州药明康德新药开发股份有限公司 | 添加稳定剂的生物基质的制备方法 |
US10945428B2 (en) | 2016-03-04 | 2021-03-16 | Menarini Silicon Biosystems S.P.A. | Preservation of cellular components from cells with a preservative |
EP3427060A4 (fr) | 2016-03-07 | 2019-12-18 | CFGenome, LLC | Témoins moléculaires non invasifs |
JP2017219479A (ja) | 2016-06-09 | 2017-12-14 | 住友電気工業株式会社 | 微小粒子計測装置及び分析方法 |
EP3491381A1 (fr) | 2016-07-29 | 2019-06-05 | Streck, Inc. | Composition de suspension pour contrôle d'analyse hématologique |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US10415080B2 (en) | 2016-11-21 | 2019-09-17 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
RU2764245C2 (ru) * | 2017-08-02 | 2022-01-14 | Зарштедт Аг Унд Ко. Кг | Способ и состав для стабилизации нуклеиновых кислот, свободных от клеток, и клеток |
US10844353B2 (en) | 2017-09-01 | 2020-11-24 | Gpb Scientific, Inc. | Methods for preparing therapeutically active cells using microfluidics |
CN111372451B (zh) * | 2017-10-19 | 2022-08-12 | 斯特雷克股份有限公司 | 用于胞外囊泡的溶血和凝血调节以及稳定化的组合物 |
US11549139B2 (en) | 2018-05-14 | 2023-01-10 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
JP7334468B2 (ja) * | 2018-05-29 | 2023-08-29 | 東ソー株式会社 | 血液試料保存剤 |
JP7036670B2 (ja) | 2018-05-31 | 2022-03-15 | アークレイ株式会社 | 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管 |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
CN108865976B (zh) * | 2018-07-19 | 2022-06-28 | 复旦大学附属中山医院 | 一种离散汲取收集外泌体(exosome)的方法及试剂 |
CN110250159A (zh) * | 2019-05-28 | 2019-09-20 | 天津中科生物科技有限公司 | 一种细胞保护液及其制备方法和应用 |
JP7355473B1 (ja) | 2022-03-25 | 2023-10-03 | 積水メディカル株式会社 | 循環腫瘍細胞分離キット、循環腫瘍細胞分離容器及び循環腫瘍細胞の分離方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4040785A (en) * | 1976-10-18 | 1977-08-09 | Technicon Instruments Corporation | Lysable blood preservative composition |
US4320111A (en) * | 1977-06-14 | 1982-03-16 | American Home Products Corporation | Immunologic compositions methods of preparation and use |
FR2475737A1 (fr) * | 1980-02-07 | 1981-08-14 | Pasteur Institut | Perfectionnements apportes aux procedes de conservation d'hematies par lyophilisation en vue de leur utilisation dans des reactions d'hemagglutination et hematies non agglutinables spontanement obtenues par ce procede |
US4404181A (en) * | 1981-10-15 | 1983-09-13 | Cambridge Chemical Products, Inc. | Extended-life tissue fixative composition and method of using the same |
FR2523810B1 (fr) * | 1982-03-23 | 1988-11-25 | Carpentier Alain | Tissu biologique greffable et procede pour sa preparation |
FR2528848A1 (fr) * | 1982-06-16 | 1983-12-23 | Sanofi Sa | Nouveau derive de thieno-pyridone, son procede de preparation et son application therapeutique |
EP0156537A3 (fr) * | 1984-03-02 | 1987-05-13 | Board Of Regents University Of Texas System | Fluide magnétique biologique |
US4654312A (en) * | 1984-05-14 | 1987-03-31 | Becton, Dickinson And Company | Lysing agent for analysis of peripheral blood cells |
US4788139A (en) * | 1987-08-06 | 1988-11-29 | Streck Laboratories, Inc. | Platelet aggregation reagent, reagent container and method of determining platelet aggregation in EDTA-anticoagulated blood |
US5385707A (en) * | 1988-12-28 | 1995-01-31 | Stefan Miltenyi | Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same |
US5698271A (en) * | 1989-08-22 | 1997-12-16 | Immunivest Corporation | Methods for the manufacture of magnetically responsive particles |
US5849517A (en) * | 1991-05-08 | 1998-12-15 | Streck Laboratories, Inc. | Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
EP0627879A1 (fr) * | 1991-09-20 | 1994-12-14 | CAMIENER, Gerald, W. | Procedes et compositions comportant une solution de stabilisation a l'aldehyde |
AU6235994A (en) * | 1993-02-25 | 1994-09-14 | Abbott Laboratories | Multipurpose reagent system for rapid lysis of whole blood samples |
US6190870B1 (en) * | 1995-08-28 | 2001-02-20 | Amcell Corporation | Efficient enrichment and detection of disseminated tumor cells |
GB2313288B (en) * | 1996-05-24 | 2000-07-12 | North Gen Hospital Nhs Trust | Specimen collection fluid |
US6197523B1 (en) * | 1997-11-24 | 2001-03-06 | Robert A. Levine | Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood |
US6670197B2 (en) * | 1997-11-24 | 2003-12-30 | David L. Rimm | Method for assaying whole blood for the presence or absence of circulating cancer or other target cell fragments |
WO1999041613A1 (fr) * | 1998-02-12 | 1999-08-19 | Immunivest | Methodes et reactifs pour l'isolation rapide et efficace de cellules cancereuses circulantes |
WO2000047998A1 (fr) * | 1999-02-10 | 2000-08-17 | Cell Works Inc. | Caracterisation de classes de cellules cancereuses circulantes isolees a partir de fluides corporels et methodes d'utilisation |
WO2001019956A2 (fr) * | 1999-09-13 | 2001-03-22 | Bander Neil H | Procede d'isolement de cellules epitheliales prostatiques du sperme |
JP2005501236A (ja) * | 2001-08-23 | 2005-01-13 | イムニベスト・コーポレイション | 分析用の細胞および生物学的検体の安定化 |
-
2002
- 2002-08-23 JP JP2003523608A patent/JP2005501236A/ja active Pending
- 2002-08-23 EP EP02768676A patent/EP1425383A4/fr not_active Withdrawn
- 2002-08-23 IL IL16021002A patent/IL160210A0/xx unknown
- 2002-08-23 WO PCT/US2002/026861 patent/WO2003019141A2/fr active Application Filing
- 2002-08-23 BR BR0212124-7A patent/BR0212124A/pt not_active Application Discontinuation
- 2002-08-23 KR KR10-2004-7002473A patent/KR20040053115A/ko not_active Application Discontinuation
- 2002-08-23 CN CNA02820820XA patent/CN1571634A/zh active Pending
- 2002-08-23 JP JP2003523961A patent/JP2005502863A/ja active Pending
- 2002-08-23 AT AT02761478T patent/ATE401574T1/de not_active IP Right Cessation
- 2002-08-23 EP EP02761478A patent/EP1425294B2/fr not_active Expired - Lifetime
- 2002-08-23 IL IL16020902A patent/IL160209A0/xx unknown
- 2002-08-23 WO PCT/US2002/026867 patent/WO2003018757A2/fr active Application Filing
- 2002-08-23 CA CA2457894A patent/CA2457894C/fr not_active Expired - Fee Related
- 2002-08-23 BR BR0212125-5A patent/BR0212125A/pt not_active IP Right Cessation
- 2002-08-23 CN CNA028212002A patent/CN1596265A/zh active Pending
- 2002-08-23 CA CA2457891A patent/CA2457891C/fr not_active Expired - Fee Related
- 2002-08-23 KR KR10-2004-7002572A patent/KR20040030984A/ko not_active Application Discontinuation
- 2002-08-23 DE DE60227678T patent/DE60227678D1/de not_active Expired - Lifetime
-
2008
- 2008-12-24 AU AU2008288601A patent/AU2008288601B2/en not_active Ceased
-
2009
- 2009-01-02 AU AU2009200013A patent/AU2009200013B2/en not_active Ceased
- 2009-01-21 JP JP2009011194A patent/JP2009109514A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1571634A (zh) | 2005-01-26 |
EP1425294B1 (fr) | 2008-07-16 |
CA2457891C (fr) | 2019-10-01 |
DE60227678D1 (de) | 2008-08-28 |
IL160210A0 (en) | 2004-07-25 |
BR0212124A (pt) | 2004-07-20 |
EP1425294A4 (fr) | 2005-11-16 |
KR20040030984A (ko) | 2004-04-09 |
WO2003018757A2 (fr) | 2003-03-06 |
JP2009109514A (ja) | 2009-05-21 |
WO2003019141A2 (fr) | 2003-03-06 |
CN1596265A (zh) | 2005-03-16 |
WO2003019141A3 (fr) | 2004-04-01 |
AU2008288601B2 (en) | 2012-05-31 |
AU2009200013B2 (en) | 2012-03-08 |
CA2457891A1 (fr) | 2003-03-06 |
EP1425294A2 (fr) | 2004-06-09 |
WO2003018757A3 (fr) | 2003-09-12 |
CA2457894A1 (fr) | 2003-03-06 |
ATE401574T1 (de) | 2008-08-15 |
CA2457894C (fr) | 2014-07-08 |
JP2005501236A (ja) | 2005-01-13 |
EP1425294B2 (fr) | 2012-12-12 |
KR20040053115A (ko) | 2004-06-23 |
JP2005502863A (ja) | 2005-01-27 |
EP1425383A4 (fr) | 2005-11-09 |
AU2009200013A1 (en) | 2009-02-05 |
EP1425383A2 (fr) | 2004-06-09 |
BR0212125A (pt) | 2005-06-28 |
AU2008288601A1 (en) | 2009-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160209A0 (en) | Analysis of circulating tumor cells, fragments, and debris | |
US9134237B2 (en) | High sensitivity multiparameter method for rare event analysis in a biological sample | |
Lazar et al. | Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line | |
NZ333830A (en) | Method for assessing chemosensitivity of a biopsy sample | |
WO2003106157A3 (fr) | Appareil automatique de coloration des lames | |
WO2008109414A3 (fr) | Utilisation de la fluorescence endogène pour identifier les cellules de tumeur du sein métastatiques envahissantes | |
de Paz et al. | The relationship between ram sperm head morphometry and fertility depends on the procedures of acquisition and analysis used | |
Kervarrec et al. | Merkel cell carcinomas infiltrated with CD33+ myeloid cells and CD8+ T cells are associated with improved outcome | |
Subramanian et al. | Significance of bone marrow fibrosis in multiple myeloma | |
Teman et al. | Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study | |
Pijanka et al. | Spectroscopic signatures of single, isolated cancer cell nuclei using synchrotron infrared microscopy | |
Cattan et al. | Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis | |
Wong et al. | MDM2/CDK4 gene amplification in large/deep-seated ‘lipomas’: incidence, predictors and clinical significance | |
Gong et al. | Clonal status and clinicopathological features of Langerhans cell histiocytosis | |
WO2019005902A1 (fr) | Système et procédés de diagnostic de biopsie liquide quantitative | |
Zver et al. | Minimal residual disease detection in cryopreserved ovarian tissue by multicolor flow cytometry in acute myeloid leukemia | |
WO2011033290A3 (fr) | Essai par fluorescence double | |
Toman | What are the advantages and disadvantages of fluorescence microscopy | |
Venable et al. | An analysis of endothelial microparticles as a function of cell surface antibodies and centrifugation techniques | |
Shen et al. | Accurate and noninvasive embryos screening during in vitro fertilization (IVF) assisted by Raman analysis ofembryos culture medium | |
WO2005049861A3 (fr) | Procede d'analyse de troubles cellulaires proliferatifs gynecologiques | |
Balasubramanian et al. | Isolation and characterization of circulating tumor cells (CTCs) from peripheral blood specimens of patients with advanced solid tumor malignancies (using ApoStream (TM) instrumentation) | |
Zickuhr et al. | Spatial Metabolomics co-registered with Multiplex Phenotyping for the Evaluation of Human Kidney Tissue | |
HK1049204A1 (en) | Cytological imaging system and method | |
Abrantes et al. | A case of renal cell carcinoma with abundant smooth muscle (leiomyomatous) stroma and the differential diagnosis |